Scandinavian ChemoTech AB (publ)

Scandinavian ChemoTech AB (publ)verified

CMOTEC-B.ST

Price:

$3.73

Market Cap:

$86.97M

Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Industry

Biotechnology

IPO Date

2016-12-06

Stock Exchange

STO

Ticker

CMOTEC-B.ST

The ROE as of December 2025 (TTM) for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) is -192.64%

According to Scandinavian ChemoTech AB (publ)’s latest financial reports and current stock price. The company's current ROE is -192.64%. This represents a change of 273.55% compared to the average of -51.57% of the last 4 quarters.

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) Historical ROE (quarterly & annually)

How has CMOTEC-B.ST ROE performed in the past?

The mean historical ROE of Scandinavian ChemoTech AB (publ) over the last ten years is -120.91%. The current -192.64% ROE has changed 59.32% with respect to the historical average. Over the past ten years (40 quarters), CMOTEC-B.ST's ROE was at its highest in in the December 2015 quarter at 0%. The ROE was at its lowest in in the September 2015 quarter at -509.74%.

Quarterly (TTM)
Annual

Average

-120.91%

Median

-127.82%

Minimum

-229.38%

Maximum

-23.41%

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Scandinavian ChemoTech AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 452.67%

Maximum Annual ROE = -23.41%

Minimum Annual Increase = -71.10%

Minimum Annual ROE = -229.38%

Quarterly (TTM)
Annual
YearROEChange
2024-229.38%19.97%
2023-191.20%17.61%
2022-162.56%119.13%
2021-74.19%-41.26%
2020-126.29%-2.37%
2019-129.36%452.67%
2018-23.41%-71.10%
2017-80.99%45.12%
2017-55.81%-58.95%
2016-135.94%123.54%

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) Average ROE

How has CMOTEC-B.ST ROE performed in the past?

The current ROE of Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-194.38%

5-year avg

-156.72%

10-year avg

-120.91%

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) ROE vs. Peers

How is CMOTEC-B.ST’s ROE compared to its peers?

Scandinavian ChemoTech AB (publ)’s ROE is less than Xbrane Biopharma AB (publ) (28.79%), greater than Nanologica AB (publ) (-82.60%), greater than NextCell Pharma AB (-64.37%), greater than Biosergen AB (-94.47%), greater than Biovica International AB (publ) (-149.87%), greater than Alzinova AB (publ) (-21.31%), greater than Active Biotech AB (publ) (-223.35%), greater than Neola Medical AB (publ) (-14.05%), greater than Vivesto AB (-83.88%), greater than Pila Pharma AB (publ) (-350.68%),

Build a custom stock screener for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scandinavian ChemoTech AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scandinavian ChemoTech AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Scandinavian ChemoTech AB (publ)'s ROE?

How is the ROE calculated for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)?

What is the highest ROE for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)?

What is the 3-year average ROE for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)?

What is the 5-year average ROE for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)?

How does the current ROE for Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) compare to its historical average?